FilingsAtlas Logo - Company Search & Market Tools
FilingsAtlas

cbdMD, Inc. (YCBD) Financial Statements

Industry: Perfumes, Cosmetics & Other Toilet Preparations

In fiscal 2025, cbdMD reported revenue of $19.2M, down 1.5% from $19.5M the year before. Net income was -$2.0M (a -10.6% net margin), or -$1.09 per diluted share. Gross margin was 62.4% and operating margin was -11.3%. Operating activities generated -$1.5M of cash, leaving -$1.6M of free cash flow. At fiscal year end, cbdMD held $10.4M in total assets against $3.2M in total liabilities, including $2.3M of cash and equivalents.

Open the full interactive cbdMD financials → Quarterly statements, key ratios, valuation history and price charts.

cbdMD Key Stats

Share Price$0.35
Market Cap$3.8M
Revenue YoY Growth-1.5%
52-Week Range$0.35 – $2.27
Shares Outstanding10.6 million (basic, 2026 Q3)

cbdMD Income Statement

cbdMD, Inc. annual income statement
FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue$41.9M$44.5M$35.4M$24.2M$19.5M$19.2M
Gross Profit$26.4M$30.0M$22.3M$15.0M$12.0M$12.0M
Operating Income-$17.6M-$19.6M-$78.3M-$22.5M-$3.3M-$2.2M
Pre-Tax Income$11.3M-$23.4M-$70.1M-$22.9M-$3.7M-$2.0M
Income Tax-$1.3M$895,000$0$0$0$0
Net Income$12.6M-$23.4M-$70.1M-$22.9M-$3.7M-$2.0M
Diluted EPS$100.80-$169.20-$446.40-$106.56-$14.32-$1.09

cbdMD Quarterly Results

cbdMD, Inc. last 4 quarters
2025 Q42026 Q12026 Q22026 Q3
Revenue$4.7M$5.0M$5.6M$5.6M
Net Income-$679,968-$283,131-$797,978-$1.1M
Diluted EPS-$0.17———

cbdMD Balance Sheet

cbdMD, Inc. annual balance sheet (fiscal year end)
FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Cash & Equivalents$14.8M$26.4M$6.7M$1.8M$2.5M$2.3M
Current Assets$23.7M$36.5M$16.0M$8.1M$6.4M$6.6M
Total Assets$110.8M$124.9M$40.8M$16.2M$10.6M$10.4M
Current Liabilities$7.7M$6.9M$5.3M$4.7M$8.6M$3.2M
Total Long-Term Debt$1.5M$108,985$125,491$9——
Total Liabilities$31.7M$21.7M$9.4M$7.2M$8.6M$3.2M
Shareholders' Equity$79.2M$103.1M$31.4M$9.0M$2.0M$7.2M

cbdMD Cash Flow Statement

cbdMD, Inc. annual cash flow statement
FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Cash From Operations-$10.7M-$14.1M-$15.0M-$4.3M-$352,792-$1.5M
Cash From Investing-$1.6M-$2.6M-$688,680$702,451-$290,015-$184,172
Cash From Financing$22.4M$28.2M-$4.0M-$1.3M$1.3M$1.4M
Free Cash Flow-$12.0M-$14.4M-$15.7M-$4.6M-$542,807-$1.6M
Dividends Paid$366,850$2.6M————

Figures from cbdMD's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full cbdMD financials page for every line item.

cbdMD Company Profile

TickerYCBD
ExchangeNYSE
IndustryPerfumes, Cosmetics & Other Toilet Preparations
HeadquartersCharlotte, North Carolina
Incorporated inNorth Carolina
Fiscal Year EndSeptember 30
SEC Filer CategoryNon-accelerated filer, smaller reporting company
SEC CIK0001644903

Frequently Asked Questions

What was cbdMD's revenue in fiscal 2025?

cbdMD (YCBD) reported revenue of $19.2M for fiscal 2025.

What is cbdMD's annual revenue history?

cbdMD's annual revenue by fiscal year: 2020: $41.9M; 2021: $44.5M; 2022: $35.4M; 2023: $24.2M; 2024: $19.5M; 2025: $19.2M.

What was cbdMD's net income in fiscal 2025?

cbdMD reported net income of -$2.0M for fiscal 2025.

What was cbdMD's earnings per share (EPS) in fiscal 2025?

cbdMD's diluted EPS was -$1.09 for fiscal 2025 (adjusted for any later stock splits).

How much free cash flow did cbdMD generate in fiscal 2025?

cbdMD generated -$1.6M of free cash flow in fiscal 2025.

What was cbdMD's revenue last quarter?

In its most recent reported quarter (2026 Q3), cbdMD reported revenue of $5.6M.

How many shares of cbdMD are outstanding?

cbdMD reported a weighted average of 10.6 million basic shares outstanding in 2026 Q3.

What is cbdMD's market cap?

Based on its latest closing price, cbdMD (YCBD) has a market capitalization of about $3.8M.

When does cbdMD's fiscal year end?

cbdMD's fiscal year end, as registered with the SEC, is September 30.

Where is cbdMD headquartered?

cbdMD lists its business address in Charlotte, North Carolina in its SEC filings.